Works by Qian, Chao-Nan

Results: 52
    1

    Phase I trial of adoptively transferred tumor-infiltrating lymphocyte immunotherapy following concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.

    Published in:
    OncoImmunology, 2015, v. 4, n. 2, p. N.PAG, doi. 10.4161/23723556.2014.976507
    By:
    • Zeng, Yi-Xin;
    • Li, Jiang;
    • He, Jia;
    • Li, Ze-Lei;
    • Tang, Xiao-Feng;
    • Chen, Shi-Ping;
    • Li, Yong-Qiang;
    • Huang, Li-Xi;
    • Ye, Shu-bio;
    • Ke, Miao-La;
    • Xia, Jian-Chuan;
    • Zhang, Xiao-Shi;
    • Zheng, Li-Min;
    • Chen, Qiu-Yan;
    • Tang, Lin-Quan;
    • Liu, Huai;
    • Zhang, Lu;
    • Guo, Shan-Shan;
    • Guo, Xiang;
    • Qian, Chao-Nan
    Publication type:
    Article
    2
    3
    4

    As an independent unfavorable prognostic factor, IL-8 promotes metastasis of nasopharyngeal carcinoma through induction of epithelial–mesenchymal transition and activation of AKT signaling.

    Published in:
    Carcinogenesis, 2012, v. 33, n. 7, p. 1302, doi. 10.1093/carcin/bgs181
    By:
    • Li, Xin-Jian;
    • Peng, Li-Xia;
    • Shao, Jian-Yong;
    • Lu, Wen-Hua;
    • Zhang, Jia-Xing;
    • Chen, Shi;
    • Chen, Zhi-Yuan;
    • Xiang, Yan-Qun;
    • Bao, Ying-Na;
    • Zheng, Fang-Jing;
    • Zeng, Mu-Sheng;
    • Kang, Tie-Bang;
    • Zeng, Yi-Xin;
    • Teh, Bin Tean;
    • Qian, Chao-Nan
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 23, p. 1761, doi. 10.1093/jnci/djr432
    By:
    • Chen, Qiu-Yan;
    • Wen, Yue-Feng;
    • Guo, Ling;
    • Liu, Huai;
    • Huang, Pei-Yu;
    • Mo, Hao-Yuan;
    • Li, Ning-Wei;
    • Xiang, Yan-Qun;
    • Luo, Dong-Hua;
    • Qiu, Fang;
    • Sun, Rui;
    • Deng, Man-Quan;
    • Chen, Ming-Yuan;
    • Hua, Yi-Jun;
    • Guo, Xiang;
    • Cao, Ka-Jia;
    • Hong, Ming-Huang;
    • Qian, Chao-Nan;
    • Mai, Hai-Qiang
    Publication type:
    Article
    16
    17

    Cetuximab or nimotuzumab plus intensity-modulated radiotherapy versus cisplatin plus intensity-modulated radiotherapy for stage II-IVb nasopharyngeal carcinoma.

    Published in:
    International Journal of Cancer, 2017, v. 141, n. 6, p. 1265, doi. 10.1002/ijc.30819
    By:
    • You, Rui;
    • Sun, Rui;
    • Hua, Yi‐Jun;
    • Li, Chao‐Feng;
    • Li, Ji‐Bin;
    • Zou, Xiong;
    • Yang, Qi;
    • Liu, You‐Ping;
    • Zhang, Yi‐Nuan;
    • Yu, Tao;
    • Cao, Jing‐Yu;
    • Zhang, Meng‐Xia;
    • Jiang, Rou;
    • Mo, Hao‐Yuan;
    • Guo, Ling;
    • Cao, Ka‐Jia;
    • Lin, Ai‐Hua;
    • Qian, Chao‐Nan;
    • Sun, Ying;
    • Ma, Jun
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.

    Published in:
    Oncogene, 2003, v. 22, n. 43, p. 6810, doi. 10.1038/sj.onc.1206869
    By:
    • Takahashi, Masayuki;
    • Yang, Ximing J;
    • Sugimura, Jun;
    • Backdahl, Jesper;
    • Tretiakova, Maria;
    • Qian, Chao-Nan;
    • Gray, Steven G;
    • Knapp, Robert;
    • Anema, John;
    • Kahnoski, Richard;
    • Nicol, David;
    • Vogelzang, Nicholas J;
    • Furge, Kyle A;
    • Kanayama, Hiroomi;
    • Kagawa, Susumu;
    • Teh, Bin Tean
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36

    GTSE1 is involved in breast cancer progression in p53 mutation-dependent manner.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1157-4
    By:
    • Lin, Fen;
    • Xie, Yu-Jie;
    • Zhang, Xin-Ke;
    • Huang, Tie-Jun;
    • Xu, Hong-Fa;
    • Mei, Yan;
    • Liang, Hu;
    • Hu, Hao;
    • Lin, Si-Ting;
    • Luo, Fei-Fei;
    • Lang, Yan-Hong;
    • Peng, Li-Xia;
    • Qian, Chao-Nan;
    • Huang, Bi-Jun
    Publication type:
    Article
    37

    Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, p. 1, doi. 10.1186/s13046-018-0692-8
    By:
    • Qiang, Yuan-Yuan;
    • Li, Chang-Zhi;
    • Sun, Rui;
    • Zheng, Li-Sheng;
    • Peng, Li-Xia;
    • Yang, Jun-Ping;
    • Meng, Dong-Fang;
    • Lang, Yan-Hong;
    • Mei, Yan;
    • Xie, Ping;
    • Xu, Liang;
    • Cao, Yun;
    • Wei, Wen-Wen;
    • Cao, Li;
    • Hu, Hao;
    • Yang, Qin;
    • Luo, Dong-Hua;
    • Liang, Ying-Ying;
    • Huang, Bi-Jun;
    • Qian, Chao-Nan
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.

    Published in:
    Medical Oncology, 2013, v. 30, n. 4, p. 1, doi. 10.1007/s12032-013-0685-6
    By:
    • Liu, Huai;
    • Huang, Pei-Yu;
    • Tang, Lin-Quan;
    • Chen, Qiu-Yan;
    • Zhang, Ying;
    • Zhang, Lu;
    • Guo, Ling;
    • Luo, Dong-Hua;
    • Mo, Hao-Yuan;
    • Xiang, Yan-Qun;
    • Qiu, Fang;
    • Sun, Rui;
    • Chen, Ming-Yuan;
    • Hua, Yi-Jun;
    • Lv, Xing;
    • Wang, Lin;
    • Zhao, Chong;
    • Guo, Xiang;
    • Cao, Ka-Jia;
    • Qian, Chao-Nan
    Publication type:
    Article